DAKLINZA FDA approval date

The FDA approved DAKLINZA on 24 Jul 2015.

FDA approval date
24 Jul 2015

Drug identity has not yet been verified against registry records

Also recorded as DACLATASVIR DIHYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-07-24DayDAKLINZAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206843", "applicant_as_listed_by_fda": "BRISTOL-MYERS SQUIBB", "brand_names": ["DAKLINZA"], "active_ingredients": ["DACLATASVIR DIHYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150724", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026